CCB
GILD icon

Cutter & Co Brokerage’s Gilead Sciences GILD Stock Holding History

Cutter & Co Brokerage’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-6,423
Closed -$720K – 62
2025
Q1 		$720K Buy
6,423
+1,972
+44% +$203K 0.17% 81
2024
Q4 		$411K Buy
4,451
+8
+0.2% +$720 0.1% 110
2024
Q3 		$372K Buy
4,443
+147
+3% +$11.2K 0.08% 122
2024
Q2 		$295K Buy
4,296
+115
+3% +$7.67K 0.07% 141
2024
Q1 		$306K Buy
4,181
+8
+0.2% +$615 0.08% 140
2023
Q4 		$338K Buy
4,173
+180
+5% +$14K 0.09% 124
2023
Q3 		$299K Buy
3,993
+6
+0.2% +$461 0.09% 134
2023
Q2 		$307K Buy
3,987
+519
+15% +$41.4K 0.09% 139
2023
Q1 		$288K Buy
3,468
+63
+2% +$5.22K 0.09% 157
2022
Q4 		$292K Buy
+3,405
New +$270K 0.1% 155
2019
Q1 		– Sell
-5,626
Closed -$352K – 296
2018
Q4 		$352K Sell
5,626
-14,545
-72% -$1.02M 0.13% 160
2018
Q3 		$1.56M Sell
20,171
-774
-4% -$58.5K 0.53% 58
2018
Q2 		$1.48M Sell
20,945
-627
-3% -$44.3K 0.57% 52
2018
Q1 		$1.63M Buy
21,572
+1,067
+5% +$84.8K 0.64% 44
2017
Q4 		$1.47M Sell
20,505
-990
-5% -$75.2K 0.6% 43
2017
Q3 		$1.74M Sell
21,495
-400
-2% -$30.6K 0.69% 42
2017
Q2 		$1.55M Sell
21,895
-489
-2% -$32.5K 0.61% 47
2017
Q1 		$1.52M Sell
22,384
-874
-4% -$61.5K 0.63% 45
2016
Q4 		$1.67M Sell
23,258
-1,197
-5% -$89K 0.69% 46
2016
Q3 		$1.94M Buy
24,455
+660
+3% +$53.6K 0.84% 33
2016
Q2 		$1.99M Buy
23,795
+1,068
+5% +$94.8K 0.85% 36
2016
Q1 		$2.09M Buy
22,727
+4,731
+26% +$427K 0.96% 28
2015
Q4 		$1.82M Sell
17,996
-75
-0.4% -$7.8K 0.85% 34
2015
Q3 		$1.77M Sell
18,071
-1,949
-10% -$216K 0.87% 37
2015
Q2 		$2.34M Buy
20,020
+2,690
+16% +$294K 0.93% 32
2015
Q1 		$1.7M Buy
17,330
+605
+4% +$61.4K 0.69% 44
2014
Q4 		$1.58M Buy
+16,725
New +$1.73M 0.6% 51

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Cutter & Co Brokerage's GILD Position: Q2 2025 in Review

Cutter & Co Brokerage sold out of Gilead Sciences (GILD) in Q2 2025, closing a stake of 6,423 shares — an estimated $720K sold.

Cutter & Co Brokerage first reported a position in GILD in Q4 2014 and held it in 27 quarters. The position peaked at $2.34M in Q2 2015. 2,024 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

  • Cutter & Co Brokerage reported no remaining Gilead Sciences position as of Q2 2025 after selling out during the quarter.
  • Cutter & Co Brokerage sold 6,423 Gilead Sciences shares in Q2 2025, an estimated $720K.
  • Cutter & Co Brokerage first reported a position in Gilead Sciences in Q4 2014 and held it in 27 quarters.
  • Cutter & Co Brokerage's Gilead Sciences position peaked at $2.34M in Q2 2015.
  • 2,024 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on Cutter & Co Brokerage's 13F filing for Q2 2025.